Skip to main content
. 2017 Jun 29;165(3):573–583. doi: 10.1007/s10549-017-4358-6

Fig. 1.

Fig. 1

PlanB CONSORT diagram. CT chemotherapy, ET endocrine therapy, HR hormone receptor, RS recurrence score